Billionaire Philippe Laffont Just Dumped CoreWeave and Opened a Position in a Stock That Soared Nearly 50% in January.The Motley Fool • 02/21/26
Moderna got the FDA to change its mind and review its flu vaccine after some concessionsMarket Watch • 02/18/26
Moderna Announces the U.S. Food and Drug Administration will Initiate the Review of Its Investigational Seasonal Influenza Vaccine SubmissionAccesswire • 02/18/26
Moderna Receives European Commission Marketing Authorization for COVID-19 Vaccine mNEXSPIKEAccesswire • 02/17/26